Defense Mechanisms of the Respiratory Tract

  • Ramon G. Canto
  • George R. Robinson
  • Herbert Y. Reynolds
Part of the Infectious Agents and Pathogenesis book series (IAPA)

Abstract

The human respiratory tract, with its primary function of moving ambient air into intimate contact with blood for gas exchange, is constantly confronted with a multitude of noxious agents and elements that abound in the environment, including a variety of microbial pathogens. Moreover, the nasooropharynx is heavily colonized with a diverse group of microorganisms that can be aspirated into the lower airways. It is therefore remarkable that respiratory infections are not more common and are usually not serious for most humans. The host defense apparatus of the lung is responsible for this protection. This system consists of structural, mechanical, secretory, and cellular mechanisms that are designed to eliminate or contain the majority of these pathogenic agents (Table I). The human host is rendered more susceptible to pulmonary infections if any of the system’s components malfunctions or if the system is overwhelmed by a new microbe, a particularly virulent microbial strain, or a large inoculum dose.

Keywords

Pneumonia Superoxide Bacillus Interferon Smoke 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Reynolds, H. Y., 1983, Altered lung host defenses and infection, in: Respiratory Infections: Diagnosis and Management (J. E. Pennington, ed.), Raven, New York, pp. 1–23.Google Scholar
  2. 2.
    Rutland, W., Griffin, M., and Cole, P. J., 1982, Human ciliary beat frequency in epithelium from intrathoracic and extrathoracic airways, Am. Rev. Respir. Dis. 125:100–105.PubMedGoogle Scholar
  3. 3.
    Wanner, A., 1977, Clinical aspects of mucociliary transport (state of the art), Am. Rev. Respir. Dis. 116:73–125.PubMedGoogle Scholar
  4. 4.
    Reid, L., 1965, Natural history of mucus in the bronchial tree. Arch. Environ. Health. 10: 265–272.PubMedCrossRefGoogle Scholar
  5. 5.
    Toremalm, N. G., 1960, The daily amount of tracheobronchial secretions in man. Acta Otolaryngol (Suppl). 158:43–46.CrossRefGoogle Scholar
  6. 6.
    Eliasson, R., Mossberg, B., Camner, P., and Afzelius, B. A., 1977, The immotile cilia syndrome: A congenital ciliary abnormality as an etiologic factor in chronic airway infections and male sterility. N. Engl. J. Med. 297:1–6.PubMedCrossRefGoogle Scholar
  7. 7.
    Wilson, R., Pitt, T., Taylor, G., Watson, D., MacDermott, J., Sykes, D., Roberts, D., and Cole, P., 1987, Pyocyanin and 1-hydroxyphenazine produced by Pseudomonas aeruginosa inhibit the beating of human respiratory cilia in vitro. J. Clin. Invest. 79:221–229.CrossRefGoogle Scholar
  8. 8.
    Gail, D. B., and Lenfant, C. J. M., 1983, Cells of the lung: Biology and clinical implications (state of the art), Am. Rev. Respir. Dis. 127:366–387.PubMedGoogle Scholar
  9. 9.
    Reid, L., and Jones, R., 1979, Bronchial mucosal cells, Fed. Proc. 38:191–196.PubMedGoogle Scholar
  10. 10.
    Hogg, J. C., Pare, P. D., and Boucher, R. C., 1979, Bronchial mucosal permeability, Fed. Proc. 38:197–201.PubMedGoogle Scholar
  11. 11.
    Reid, L., 1960, Measurement of the bronchial mucous gland layer: A diagnostic yardstick in chronic bronchitis, Thorax 15:132–141.PubMedCrossRefGoogle Scholar
  12. 12.
    Mackowiak, P. A., 1982, The normal microbial flora, N. Engl. J. Med. 307:83–93.PubMedCrossRefGoogle Scholar
  13. 13.
    Reynolds, H. Y., 1987, Bacterial adherence to respiratory tract mucosa—a dynamic interaction leading to colonization, Semin. Respir. Med. 2:8–19.Google Scholar
  14. 14.
    Gibbons, R. J., and van Houte, J., 1975, Bacterial adherence in oral microbial ecology, Ann. Rev. Microbiol. 29:19–44.CrossRefGoogle Scholar
  15. 15.
    LaForce, F. M., Hopkins, J., Trow, R., and Wang, W. L. L., 1976, Human oral defenses against gram-negative rods, Am. Rev. Respir. Dis. 124:929–935.Google Scholar
  16. 16.
    Johanson, W. G., Higuchi, J. H., Chaudhuri, T. R., and Woods, D. E., 1980, Bacterial adherence to epithelial cells in bacillary colonization of the respiratory tract, Am. Rev. Respir. Dis. 121:55–63.PubMedGoogle Scholar
  17. 17.
    Merrill, W. W., Goodenberg, D., Strober, W., Matthay, R. A., Naegel, G. P., and Reynolds, H. Y., 1980, Free secretory component and other proteins in human lung lavage, Am. Rev. Respir. Dis. 122:156–161.PubMedGoogle Scholar
  18. 18.
    Tomasi, T. B., and Plaut, A. G., 1985, IgA in mucosal immunity, in: Advances in Host Defense Mechanisms, (J. J. Gallin and A. S. Fauci, eds.), Raven, New York, pp. 31–61.Google Scholar
  19. 19.
    Kaliner, M. A., 1992, Human nasal host defense and sinusitis. J. Allergy. Clin. Immunol. 90:424–430.PubMedCrossRefGoogle Scholar
  20. 20.
    Stamenkovi C. I., Stegagno, M., Wright, K. A., Krane, S. M., Amento, E. P., Colvin, R. B., Duquesnoy, R. J., and Kurnick, J. T., 1988, Clonal dominance among T-lymphocyte infiltrates in arthritis, Proc. Natl. Acad. Sci. USA 85:1179–1183.CrossRefGoogle Scholar
  21. 21.
    Reinherz, E. L., Kung, P. C., Goldstein, G., and Schlossman, J. F., 1979, Further characterization of the human inducer T-cell subset defined by monoclonal antibody, J. Immunol. 123: 2894–2896.PubMedGoogle Scholar
  22. 22.
    Kozbor, D., Finan, J., Nowell, P. C., and Croce, C. M., 1986, The gene encoding the T4 antigen maps to human chromosome 12. J. Immunol. 136:1141–1143.PubMedGoogle Scholar
  23. 23.
    Parnes, J. R., 1989, Molecular biology and function of CD4 and CD8, Adv. Immunol. 44: 265–311.PubMedCrossRefGoogle Scholar
  24. 24.
    Takeuchi, M., Nagai, S., and Izumi, T., 1988, Effect of smoking on natural killer cell activity in the lung, Chest 94:688–693.PubMedCrossRefGoogle Scholar
  25. 25.
    Bienenstock, J., and Befus, D., 1984, Gut and bronchus-associated lymphoid tissue, Am. J. Anat. 170:437–445.PubMedCrossRefGoogle Scholar
  26. 26.
    Bienenstock, J., 1984, Bronchus-associated lymphoid tissue, in: Immunology of the Lung and Upper Respiratory Tract (J. Bienenstock, ed), McGraw-Hill, New York, pp. 96–118.Google Scholar
  27. 27.
    Bienenstock, J., Clancy, R. L., and Perey, D. Y. E., 1976, Bronchus-associated lymphoid tissue (BALT): Its relationship to mucosal immunity, in: Immunologic and Infectious Reactions in the Lung, (C. H. Kirkpatrick and H. Y. Reynolds, eds.) Marcel Dekker, New York, pp. 29–58.Google Scholar
  28. 28.
    Racz, P., Tenner-Racz, K., Myrvik, Q. N., and Fainter, L. K., 1977, Functional architecture of bronchial-associated lymphoid tissue and lymphoepithelium in pulmonary cell-mediated reactions in the rabbit, J. Reticuloendothel. Soc. 22:59–83.PubMedGoogle Scholar
  29. 29.
    Bienenstock, J., 1985, Bronchus-associated lymphoid tissue, Int. Arch. Allerg. Appl. Immunol. 76(Suppl 1): 62–69.CrossRefGoogle Scholar
  30. 30.
    Racz, P., Tenner-Racz, K., Myrvik, Q. N., Shannon, B. T., and Love, S. H., 1978, Sinus reactions in the hilar lymph node complex of rabbits undergoing a pulmonary cell-mediated immune response: Sinus macrophage clumping reaction, sinus lymphocytosis and immature sinus histiocytosis, J. Reticuloendothel. Soc. 24:499–525.PubMedGoogle Scholar
  31. 31.
    Sertl, K., Takemura, T., Tschachler, E., Ferrans, V. J., Kaliner, M. A., and Shevach, E. M., 1986, Dendritic cells with antigen-presenting capability reside in airway epithelium, lung parenchyma and visceral pleura, J. Exp. Med. 163:436–451.PubMedCrossRefGoogle Scholar
  32. 32.
    Fick, R. B., Richerson, H. B., Zavala, D. C., and Hunninghake, G. W., 1987, Broncho-alveolar lavage in allergic asthmatics, Am. Rev. Respir. Dis. 135:1204–1209.PubMedGoogle Scholar
  33. 33.
    Rankin, J. A., Marcy, T., Rochester, C. L., Sussman, J., Smith, S., Buckley, P., and Lee, D., 1992, Human airway macrophages, Am. Rev. Respir. Dis. 145:928–933.PubMedCrossRefGoogle Scholar
  34. 34.
    Soler, P., Moreau, A., Basset, F., and Hance, A. J., 1989, Cigarette smoking-induced changes in the number and differentiated state of pulmonary dendritic cells/Langerhans cells, Am. Rev. Respir. Dis. 139:1112–1117.PubMedCrossRefGoogle Scholar
  35. 35.
    Reynolds, H. Y., and Chretien, J., 1984, Respiratory tract fluids: Analysis of content and contemporary use in understanding lung diseases. Disease-A-Month 30:1–103.PubMedCrossRefGoogle Scholar
  36. 36.
    Rennard, S. I., Hunninghake, G. W., Bitterman, P. B., and Crystal, R. G., 1981, Production of fibronectin by the human alveolar macrophage: A mechanism for the recruitment of fibroblasts to sites of tissue injury in the interstitial lung diseases, Proc. Natl. Acad. Sci. USA 78:7147–7151.PubMedCrossRefGoogle Scholar
  37. 37.
    Mold, C., Rogers, C. P., Kaplan, R. L., and Gewurz, H., 1982, Binding of human C-reactive protein to bacteria, Infect. Immun. 38:392–395.PubMedGoogle Scholar
  38. 38.
    Bell, D. Y., Haseman, J. A., Spock, A., McLennan, G., and Hook, G. E. R., 1981, Plasma proteins of the broncho-alveolar surface of the lungs of smokers and non-smokers, Am. Rev. Respir. Dis. 124:72–79.PubMedGoogle Scholar
  39. 39.
    Lewis, J. F., and Jobe, A. H., 1993, Surfactant and the adult respiratory syndrome (state of the art), Am. Rev. Respir. Dis. 147:218–233.PubMedCrossRefGoogle Scholar
  40. 40.
    Coonrod, J. D., Lester, R. L., and Hsu, L. C., 1984, Characterization of the extracellular bactericidal factors of rat alveolar lining material, J. Clin. Invest. 74:1269–1279.PubMedCrossRefGoogle Scholar
  41. 41.
    Jonsson, S., Musher, D. M., Goree, A., and Lawrence, E. C., 1986, Human alveolar lining material and antibacterial defenses, Am. Rev. Respir. Dis. 133:136–140.PubMedGoogle Scholar
  42. 42.
    Sherman, M. P., D’Ambola, J. B., Aeberhard, E. E., and Barrett, C. T., 1988, Surfactant therapy of newborn rabbits impairs macrophage bactericidal activity, J. Appl. Physiol. 56: 137–145.Google Scholar
  43. 43.
    Speer, C. P., Gotze, B., Curstedt, T., and Robertson, B., 1991, Phagocytic functions and tumor necrosis factor secretion of human monocytes exposed to natural porcine surfactant (Curosurf), Pediatr Res. 30:69–74.PubMedCrossRefGoogle Scholar
  44. 44.
    Weber, H., Heilmann, P., Meyer, B., and Maier, K. L., 1990, Effect of canine surfactant protein (SP-A) on the respiratory burst of phagocytic cells, FEBS Lett. 270:90–94.PubMedCrossRefGoogle Scholar
  45. 45.
    van Iwaarden, J. F., Weimers, B., Verhoef, J., Haagsman, H.P., and van Golde, L. M. G., 1990, Pulmonary surfactant protein A enhances the host-defense mechanism of rat alveolar macrophages, Am. J. Respir. Cell Mol. Biol. 2:91–98.PubMedCrossRefGoogle Scholar
  46. 46.
    Hoffman, R. M., Claypool, W. D., Katyal, S. L., Singh, G., Rogers, R. M., and Dauber, J. H., 1987, Augmentation of rat alveolar macrophage migration by surfactant protein, Am. Rev. Respir. Dis. 135:1358–1362.PubMedGoogle Scholar
  47. 47.
    Thomassen, M. J., Lee, F., Meeker, D., Antal, J., Connors, M., and Wiedemann, H., 1992, Synthetic surfactant (Exosurf) inhibits endotoxin-stimulated cytokine secretion by human alveolar macrophages (abstract), Am. Rev. Respir. Dis. 145:A876.Google Scholar
  48. 48.
    Merrill, W. W., Naegel, G. P., Olchowski, J. J., and Reynolds, H. Y., 1985, Immunoglobulin G subclass proteins in serum and lavage fluid of normal subjects: Quantitation and comparison with immunoglobulins A and E, Am. Rev. Respir. Dis. 131:584–591.PubMedGoogle Scholar
  49. 49.
    Reynolds, H. Y., Atkinson, J. P., Newball, H. H., and Frank, M. M., 1975, Receptors for immunoglobulin and complement on human alveolar macrophages, J. Immunol. 114:1813–1819.PubMedGoogle Scholar
  50. 50.
    Sibille, Y., Chatelain, B., Staquet, P., Merrill, W. W., Delacroix, D. L., and Vaerman, J. P., 1989, Surface IgA and Fc-alpha receptors on human alveolar macrophages from normals and patients with sarcoidosis, Am. Rev. Respir. Dis. 139:740–747.PubMedCrossRefGoogle Scholar
  51. 51.
    Cole, F. S., Matthews, W. J., Rossing, T. H., Gash, D. J., Lichtenberg, N.A., and Pennington, J. E., 1983, Complement biosynthesis by human bronchoalveolar macrophages, Clin. Immunol. Immunopathol. 27:153–159.PubMedCrossRefGoogle Scholar
  52. 52.
    Robertson, J., Caldwell, J. R., Castle, J. R., and Waldman, R. H., 1976, Evidence for the presence of components of the alternate (properdin) pathway of complement activation in respiratory secretions, J. Immunol. 117:900–903.PubMedGoogle Scholar
  53. 53.
    Peters, M. G., Ambrus, J. L., Fauci, A. S., and Brown, E. J., 1988, The Bb fragment of complement factor B acts as a B cell growth factor, J. Exp. Med. 168:1225–1235.PubMedCrossRefGoogle Scholar
  54. 54.
    Sundsmo, J. S., and Gotze, O., 1981, Human monocyte spreading induced by factor Bb of the alternative pathway of complement activation, J. Exp. Med. 154:763–777.PubMedCrossRefGoogle Scholar
  55. 55.
    Gross, G. N., Rehn, S. R., and Pierce, A. K., 1978, The effect of complement depletion on lung clearance of bacteria, J. Clin. Invest. 62:373–378.PubMedCrossRefGoogle Scholar
  56. 56.
    Toews, G. B., and Vial, W. C., 1984, The role of C5 in polymorphonuclear leukocyte recruitment in response to Streptococcus pneumoniae, Am. Rev. Respir. Dis. 129:82–86.Google Scholar
  57. 57.
    Toews, G. B., and Pierce, A. K., 1984, The fifth component of complement is not required for clearance of Staphylococcus aureus, Am. Rev. Respir. Dis. 129:597–601.Google Scholar
  58. 58.
    Reynolds, H. Y., and Newball, H. H., 1974, Analysis of proteins and respiratory cells obtained from human lungs by bronchial lavage, J. Lab. Clin. Med. 84:559–573.PubMedGoogle Scholar
  59. 59.
    Dehring, D. J., and Wismar, B. L., 1987, Intravascular macrophages in pulmonary capillaries in humans, Am. Rev. Respir. Dis. 139:1027–1029.CrossRefGoogle Scholar
  60. 60.
    Warner, A. E., Molina, R. M., and Brain, J. D., 1987, Uptake of blood-borne bacteria by pulmonary intravascular macrophages and consequent inflammatory responses in sheep, Am. Rev. Respir. Dis. 136:683–690.PubMedCrossRefGoogle Scholar
  61. 61.
    Brannen, A. L., and Chandler, D. B., 1988, Alveolar macrophage subpopulations responsiveness to chemotactic stimuli, Am. J. Pathol. 132:161–166.PubMedGoogle Scholar
  62. 62.
    Sibille, Y., and Reynolds, H. Y., 1990, Macrophages and polymorphonuclear neutrophils in lung disease and injury (state of the art), Am. Rev. Respir. Dis. 141:471–501.PubMedCrossRefGoogle Scholar
  63. 63.
    Gordon, S., 1980, Lysozyme and plasminogen activator: Constitutive and induced secretory products of mononuclear phagocytes, in: Mononuclear Phagocytes Part II (R. van Furth, ed.) Nijhoff, The Hague, The Netherlands, pp. 1273–1294.CrossRefGoogle Scholar
  64. 64.
    Hinman, L. M., Stevens, C. A., Matthay, R. A., and Gee, J. B. L., 1979, Angiotensin-convertase activities in human alveolar macrophages: Effects of cigarette smoking and sarcoidosis, Science 205:202–203.PubMedCrossRefGoogle Scholar
  65. 65.
    Hunninghake, G. W., and Crystal, R. G., 1981, Pulmonary sarcoidosis: A disorder mediated by excess helper T-lymphocyte activity at sites of disease activity, N. Eng. J. Med. 305: 429–434.CrossRefGoogle Scholar
  66. 66.
    Reynolds, H. Y., Fulmer, J. D., Kazmierowski, J. A., Roberts, W. C., Frank, M. M., and Crystal, R. G., 1977, Analysis of cellular and protein components of bronchoalveolar lavage fluid from patients with idiopathic pulmonary fibrosis and hypersensitivity pneumonitis, J. Clin. Invest. 59:165–175.PubMedCrossRefGoogle Scholar
  67. 67.
    Wallace, J. M., Barbers, R. G., Oishi, J., and Prince, H., 1984, Cellular and T lymphocyte subpopulation profiles in bronchoalveolar lavage fluid from patients with acquired immunodeficiency syndrome and pneumonitis, Am. Rev. Respir. Dis. 130:786–790.PubMedGoogle Scholar
  68. 68.
    Young, K. R., Jr., Rankin, J. A., Naegel, G. P., Paul, E. S., and Reynolds, H. Y., 1985, Bronchoalveolar lavage cells and proteins in patients with acquired immunodeficiency syndrome—an immunologic analysis, Ann. Intern. Med. 103:522–533.PubMedCrossRefGoogle Scholar
  69. 69.
    Rankin, J. A., Naegel, G. P., Schrader, C. E., Matthay, R. A., and Reynolds, H. Y., 1983, Airspace immunoglobulin production and levels in bronchoalveolar lavage fluid of normals and patients with sarcoidosis, Am. Rev. Respir. Dis. 127:442–448.PubMedGoogle Scholar
  70. 70.
    Reynolds, H. Y., 1985, Respiratory infections may reflect deficiencies in host defense mechanisms, Disease-A-Month 31:1–98.PubMedCrossRefGoogle Scholar
  71. 71.
    Reynolds, H. Y., 1988, Immunoglobulin G and its function in the human respiratory tract, Mayo Clin. Proc. 63:161–174.PubMedCrossRefGoogle Scholar
  72. 72.
    Reynolds, H. Y., 1986, Lung immunology and its contribution to the immunopathogenesis of certain lung diseases, J. Allergy Clin. Immunol. 78:833–847.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1994

Authors and Affiliations

  • Ramon G. Canto
    • 1
  • George R. Robinson
    • 1
  • Herbert Y. Reynolds
    • 2
  1. 1.Pulmonary/Critical Care DivisionUSA
  2. 2.Department of Medicine, M.S. Hershey Medical CenterThe Pennsylvania State UniversityHersheyUSA

Personalised recommendations